All the information you provide will remain private and will be used to determine if you, or someone you know, might be eligible for the study. The initial eligibility process, including the questionnaire, will take about 5-7 minutes.

Please answer the following questions to see if you or someone you know may be eligible to take part in the study.

Participate in our Clinical Trial

FILL OUT THE FORM BELOW (for the patients to be filled out)


Medvin Clinical ResearchEligible participants will be in the study up to 3 months. You will have up to 6 visits at the study center with the doctor or clinical research staff.

Several tests and assessments will be performed to monitor your health. These will include (but are not limited to):

  • Physical Exams
  • Blood tests
  • Measurements of vital signs
  • Questionnaires about how you’re feeling and how RA is affecting your health

Take control of your pain and your health!!

Medvin Clinical ResearchVolunteers are needed for a breakthrough Research study for Rheumatoid Arthritis. You don’t have to take new medications as part of the study.

Those who qualify may receive:

  • Study related medical care from study doctors at no cost
  • The investigational treatment or placebo at no cost
  • Reimbursement up to $400 for study related travel expenses
  • No insurance required


Medvin Clinical ResearchWhat is the PROTECTION Study?

The purpose of this clinical research study is to determine the efficacy (whether it works) and safety of an investigational wearable device for the treatment of Rheumatoid Arthritis.

This study is for someone who has a diagnosis of Rheumatoid Arthritis and has taken some basic medications, for example Methotrexate, Plaquenil or Sulfasalazine for at least 3 months and have not had adequate relief or had intolerance to any of these. Furthermore, the patients should NOT have been exposed to a biologic (injection or infusion for the treatment of RA) in the past.

Participants in this study will be asked to use the wearable at home, every day, for 15 minutes a day, for 3 months. The wearable has been studied in a small pilot study. Results from this study indicate that the wearable may potentially offer an alternative, non-pharmacologic option for the treatment of RA.

COVID Protocol – We are following the State mandated COVID guidelines, including distancing, masks, temperature monitoring and symptoms verification. There are only 5 visits for the study on site.